Variant · Snv
SERAC1 NM_032861.4(SERAC1):c.739-10T>G
CI-VAR-00022542Explore in graph →NM_032861.4:c.739-10T>GClinVar 139095 rs118093738
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 139095 | Benign | criteria provided, multiple submitters, no conflicts | 2 | 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome; Familial pancreatic carcinoma; Gastric cancer; Ovarian cancer; Ovarian serous cystadenocarcinoma; Thymoma; Hepatocellular carcinoma; Lung cancer | germline | 5 | Jan 20, 2026 | clinvar |